Ideal dreamy outcome but highly doubt it will be the case - i'd give it about 1% chance.
Sure some big deals are stitched on pre-clinical candidates but there's still plenty they don't know about it that pharma will see as integral to deal in notable value. Still 1-2 years of pre-clinical work in the lab and further mouse models to really set that kind of play up.
POC, stability, toxicology, pk/pd, formulation etc etc.
PAB chart, page-20
-
- There are more pages in this discussion • 880 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $27 | 6.045K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 27974124 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 8779045 | 14 |
View Market Depth
| Last trade - 11.03am 22/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
